Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bumrungrad International Hospital Achieves GHA Accreditation with "Excellence," Demonstrating its Global Leadership Position in Medical Tourism 2024-05-22 21:21
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care 2024-05-22 21:00
GV Announces Cooperation with CICC 2024-05-22 20:30
I-Mab to Participate at the Jefferies Global Healthcare Conference 2024-05-22 19:00
Waterdrop Inc. to Report First Quarter 2024 Financial Results on June 5, 2024 2024-05-22 18:00
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024 2024-05-22 15:00
GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services 2024-05-22 13:00
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016 2024-05-22 09:16
Equitable access to treatment must keep pace with latest advances in reproductive surgery 2024-05-22 09:00
Advanced Waste Management Solution for Hospitals 2024-05-22 07:00
YS Biopharma Announces Results of Extraordinary General Meeting 2024-05-22 04:15
Announcement of The Shaw Laureates 2024 2024-05-21 21:58
Oncology Events in Poland Solidify Collaboration with NCCN 2024-05-21 21:03
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub 2024-05-21 21:00
New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time 2024-05-21 21:00
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy 2024-05-21 20:00
Etiometry Awarded Frost & Sullivan's 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems 2024-05-21 20:00
Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia 2024-05-21 17:52
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome 2024-05-21 17:35
So-Young to Report First Quarter 2024 Financial Results on May 28, 2024 2024-05-21 17:00
1 86 87 88 89 90 1597